Hillrom and Welch Allyn are a part of Baxter.
23px-Flag_baxterUS.svg.png  United States
text.skipToContent text.skipToNavigation
  1. Baxter Catalog
  2. Pharmaceuticals
  3. Premixed Medications
  4. Norepinephrine Bitartrate in 5% Dextrose Injection. 4 mg / 250 mL (16 mcg/mL) in VIAFLO Plastic Container. Liquid Premix
Due to missing information on your Hillrom Direct account, you are not able to add items to the cart or continue with the checkout process. Please contact our customer support team for further assistance by clicking on "contact us".
MP_logo
Norepinephrine Bitartrate in 5% Dextrose Injection. 4 mg / 250 mL (16 mcg/mL) in VIAFLO Plastic Container. Liquid Premix
Item Number: EZPE7748
GTIN:  00303380112203
GTIN-CS:  50303380112208
Norepinephrine Bitartrate in 5% Dextrose Injection. 4mg / 250 mL (16 mcg/mL) in VIAFLO Plastic Container. Liquid Premix. NDC: 0338-0112-20
print-icon Print email-icon Email
Email PDF ✕
Specifications

Product Characteristics

Volume 250.0 ml
DEHP Free Yes
PVC Free Yes
Latex Free Yes
Shelf Life from Manufacture 12 months
Concentration 16 mcg/mL
Container Type VIAFLO
Containes Preservative No
Diluent Dextrose
Dosage Form Liquid
Polyethlene Lined No
Protect From Light Yes
Rx Only Yes
Storage Recommendations Store at room temperature [20°C to 25°C (68°F to 77°F)]; excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from light. Once the overwrap is removed; store at room temperature for up to 30 days.
Strength 4 mg / 250 mL

Carton

Units per Case 20.0
Carton Weight 11.8 lb.
Carton Length 15.0 in.
Carton Width 9.2 in.
Carton Height 9.1 in.
Carton Volume 0.73 fc

Reimbursement Information

HCPCS Code HCPCS Description
J3490 Unclassified Drugs, Injection

Information Source : CMS

Disclaimer:The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies.
Ordering Information
Item Number EZPE7748
Sales Unit case
GTIN 00303380112203
GTIN-CS 50303380112208
National Drug Code 0338011220
Documents

Documentation

Link

Package Insert Link

     203052r1